PFD 267 mg (Esbriet 267 mg)
Generic Name: pirfenidone
Pill imprint PFD 267 mg has been identified as Esbriet 267 mg.
Esbriet is used in the treatment of idiopathic pulmonary fibrosis and belongs to the drug class miscellaneous uncategorized agents. Risk cannot be ruled out during pregnancy. Esbriet 267 mg is not a controlled substance under the Controlled Substance Act (CSA).
Esbriet
- Generic Name:
- pirfenidone
- Imprint:
- PFD 267 mg
- Strength:
- 267 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous uncategorized agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Genentech, Inc.
More about Esbriet (pirfenidone)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 0 Reviews – Add your own review/rating
- Drug class: miscellaneous uncategorized agents
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
